Penny Stock Pick Report alerts investors on Top Stocks that would help investors to generate higher than average returns. Subscribe to
CEL-SCI Corporation (AMEX:CVM) decreases 7.46% to $1.24 on 1.64 million shares. The stock hit an intraday high and an intraday low of $1.31 and $1.21 respectively. In the last six months the stock went up over 276%. CEL-SCI Corporation, is engaged in the development of a product called Multikine for the treatment of cancer. It simulates the activities of a healthy person's immune system, which battles cancer every day. Multikine is multi-targeted, it is the cancer immunotherapy that both kills cancer cells in a targeted fashion and activates the general immune system to destroy the cancer. Multikine is a type of immunotherapy in that it is immunotherapy, incorporating both active and passive immune activity.
ABOUT PennyStockPickReport.com
Penny Stock Pick Report is an independent electronic publication that provides information on selected publicly traded companies. Penny Stock Pick Report is not a registered investment advisor or broker-dealer. Penny Stock Pick Report affiliates, directors, officers, and employees may purchase and sell additional shares in any company which are mentioned above and may profit in the event those shares rise in value. Please does your research before you plan to invest in any of the stocks mentioned above.